{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:32:57Z","timestamp":1793845977758,"version":"4.6.1"},"reference-count":217,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.molmet.2024.101998","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T23:41:43Z","timestamp":1722037303000},"page":"101998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Decoding the immune dance: Unraveling the interplay between beta cells and type 1 diabetes"],"prefix":"10.1016","volume":"88","author":[{"given":"Saptarshi","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravil","family":"Pokharel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon D.","family":"Piganelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2024.101998_bib1","series-title":"National Diabetes Statistics Report","year":"2024"},{"issue":"6","key":"10.1016\/j.molmet.2024.101998_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s11892-013-0433-5","article-title":"The emerging global epidemic of type 1 diabetes","volume":"13","author":"Tuomilehto","year":"2013","journal-title":"Curr Diab Rep"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/er.2018-00163","article-title":"Thyroid dysfunction and diabetes mellitus: two closely associated disorders","volume":"40","author":"Biondi","year":"2019","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.34172\/hpp.2020.18","article-title":"Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis","volume":"10","author":"Mobasseri","year":"2020","journal-title":"Health Promot Perspect"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12916-017-0958-6","article-title":"Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study","volume":"15","author":"Rogers","year":"2017","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","article-title":"Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank","volume":"6","author":"Thomas","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ecl.2021.05.007","article-title":"Diabetes in youth: a global perspective","volume":"50","author":"Kahkoska","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"11","key":"10.1016\/j.molmet.2024.101998_bib8","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.2337\/dc18-1032","article-title":"First genome-wide association study of latent autoimmune diabetes in adults reveals novel insights linking immune and metabolic diabetes","volume":"41","author":"Cousminer","year":"2018","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.molmet.2024.101998_bib9","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.2337\/db07-1736","article-title":"Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1)","volume":"57","author":"Butty","year":"2008","journal-title":"Diabetes"},{"issue":"15","key":"10.1016\/j.molmet.2024.101998_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120877","article-title":"beta Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis","volume":"3","author":"Evans-Molina","year":"2018","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3892\/mco.2013.64","article-title":"A type 2 papillary renal cell carcinoma presenting as an intracystic necrotic lesion: a case report","volume":"1","author":"Fu","year":"2013","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib12","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac184","article-title":"Inside the beta cell: molecular stress response pathways in diabetes pathogenesis","volume":"164","author":"Kulkarni","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2024.101998_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fcell.2015.00067","article-title":"Beta cell ER stress and the implications for immunogenicity in type 1 diabetes","volume":"3","author":"Marre","year":"2015","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.molmet.2024.101998_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2016.04.009","article-title":"Inherent ER stress in pancreatic islet beta cells causes self-recognition by autoreactive T cells in type 1 diabetes","volume":"72","author":"Marr\u00e9","year":"2016","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.molmet.2024.101998_bib15","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/db17-1166","article-title":"Modifying enzymes are elicited by ER stress, generating epitopes that are selectively recognized by CD4+ T cells in patients with type 1 diabetes","volume":"67","author":"Marre","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2024.101998_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639682","article-title":"Making insulin and staying out of autoimmune trouble: the beta-cell conundrum","volume":"12","author":"Carre","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.14701\/kjhbps.2011.15.2.123","article-title":"Pancreatic diabetes after distal pancreatectomy: incidence rate and risk factors","volume":"15","author":"Kim","year":"2011","journal-title":"Korean J Hepatobiliary Pancreat Surg"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib18","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2337\/db06-0345","article-title":"Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy","volume":"55","author":"Matveyenko","year":"2006","journal-title":"Diabetes"},{"issue":"20","key":"10.1016\/j.molmet.2024.101998_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162123","article-title":"Elevations in blood glucose before and after the appearance of islet autoantibodies in children","volume":"132","author":"Warncke","year":"2022","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/ng0395-284","article-title":"Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus","volume":"9","author":"Bennett","year":"1995","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.molmet.2024.101998_bib21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ng.3245","article-title":"Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers","volume":"47","author":"Onengut-Gumuscu","year":"2015","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1440-1754.2001.00658.x","article-title":"Environmental triggers of type 1 diabetes","volume":"37","author":"Couper","year":"2001","journal-title":"J\u00a0Paediatr Child Health"},{"issue":"5","key":"10.1016\/j.molmet.2024.101998_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/BF00402275","article-title":"On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth","volume":"36","author":"Ziegler","year":"1993","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2337\/diacare.29.03.06.dc05-0774","article-title":"Models for predicting type 1 diabetes in siblings of affected children","volume":"29","author":"Mrena","year":"2006","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1034\/j.1399-5448.2000.010104.x","article-title":"Type 1 diabetes in offspring of parents with type 1 diabetes: the tip of an autoimmune iceberg?","volume":"1","author":"Dorman","year":"2000","journal-title":"Pediatr Diabetes"},{"issue":"26","key":"10.1016\/j.molmet.2024.101998_bib27","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1056\/NEJMc0805398","article-title":"Concordance for islet autoimmunity among monozygotic twins","volume":"359","author":"Redondo","year":"2008","journal-title":"N Engl J Med"},{"issue":"7185","key":"10.1016\/j.molmet.2024.101998_bib28","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/bmj.318.7185.698","article-title":"Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study","volume":"318","author":"Redondo","year":"1999","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5114\/ceji.2020.103386","article-title":"Type 1 diabetes: genes associated with disease development","volume":"45","author":"Klak","year":"2020","journal-title":"Cent Eur J Immunol"},{"issue":"Suppl 22","key":"10.1016\/j.molmet.2024.101998_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/pedi.12327","article-title":"Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity","volume":"17","author":"Ilonen","year":"2016","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2337\/diab.44.1.125","article-title":"Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes Study","volume":"44","author":"Sanjeevi","year":"1995","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.molmet.2024.101998_bib32","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.2337\/diabetes.51.5.1346","article-title":"Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes","volume":"51","author":"Graham","year":"2002","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.molmet.2024.101998_bib33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s001250050514","article-title":"Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY)","volume":"39","author":"Rewers","year":"1996","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/dbi20-0054","article-title":"Screening for type 1 diabetes in the general population: a status report and perspective","volume":"71","author":"Sims","year":"2022","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib35","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/db07-1331","article-title":"HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families","volume":"57","author":"Erlich","year":"2008","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.molmet.2024.101998_bib36","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","article-title":"The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study","volume":"58","author":"Krischer","year":"2015","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.molmet.2024.101998_bib37","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2337\/dc17-0238","article-title":"Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the TEDDY study","volume":"40","author":"Krischer","year":"2017","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.molmet.2024.101998_bib38","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/pedi.13073","article-title":"HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity","volume":"21","author":"Mikk","year":"2020","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"10.1016\/j.molmet.2024.101998_bib39","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2337\/db14-1497","article-title":"Role of type 1 diabetes-associated SNPs on risk of autoantibody positivity in the TEDDY study","volume":"64","author":"T\u00f6rn","year":"2015","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/pedi.12597","article-title":"Genetics of type 1 diabetes","volume":"19","author":"Redondo","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.182.2.459","article-title":"CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation","volume":"182","author":"Krummel","year":"1995","journal-title":"J\u00a0Exp Med"},{"issue":"7","key":"10.1016\/j.molmet.2024.101998_bib42","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/5.7.1075","article-title":"The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry","volume":"5","author":"Nistic\u00f2","year":"1996","journal-title":"Hum Mol Genet"},{"issue":"6939","key":"10.1016\/j.molmet.2024.101998_bib43","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib44","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1038\/cti.2017.51","article-title":"Type 1 diabetes genome-wide association studies: not to be lost in translation","volume":"6","author":"Pociot","year":"2017","journal-title":"Clin Transl Immunology"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/genes8080209","article-title":"The genetic architecture of type 1 diabetes","volume":"8","author":"Jerram","year":"2017","journal-title":"Genes (Basel)"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib46","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.2337\/db11-0758","article-title":"PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic beta-cell apoptosis via regulation of the BH3-only protein Bim","volume":"60","author":"Santin","year":"2011","journal-title":"Diabetes"},{"issue":"7892","key":"10.1016\/j.molmet.2024.101998_bib47","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(74)90140-8","article-title":"Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies","volume":"2","author":"Bottazzo","year":"1974","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.molmet.2024.101998_bib48","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.2337\/diabetes.54.suppl_2.S52","article-title":"Autoantibodies in diabetes","volume":"54","author":"Pihoker","year":"2005","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.molmet.2024.101998_bib49","doi-asserted-by":"crossref","first-page":"a007708","DOI":"10.1101\/cshperspect.a007708","article-title":"Immunologic and metabolic biomarkers of beta-cell destruction in the diagnosis of type 1 diabetes","volume":"2","author":"Lebastchi","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib50","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4161\/isl.1.2.9433","article-title":"Downregulation of ZnT8 expression in pancreatic beta-cells of diabetic mice","volume":"1","author":"Tamaki","year":"2009","journal-title":"Islets"},{"issue":"Suppl 1","key":"10.1016\/j.molmet.2024.101998_bib51","first-page":"S20","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.molmet.2024.101998_bib52","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1172\/JCI14257","article-title":"Autoimmune type 1 diabetes: resolved and unresolved issues","volume":"108","author":"Notkins","year":"2001","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib53","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.1038\/s41467-023-42763-9","article-title":"Distinct transcriptomic profiles in children prior to the appearance of type 1 diabetes-linked islet autoantibodies and following enterovirus infection","volume":"14","author":"Lin","year":"2023","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.molmet.2024.101998_bib54","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.2337\/db11-0131","article-title":"Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct","volume":"60","author":"Howson","year":"2011","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210012","article-title":"Anti-islet autoantibodies in type 1 diabetes","volume":"24","author":"Kawasaki","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.molmet.2024.101998_bib56","doi-asserted-by":"crossref","first-page":"101565","DOI":"10.1016\/j.molmet.2022.101565","article-title":"Beta cell and immune cell interactions in autoimmune type 1 diabetes: how they meet and talk to each other","volume":"64","author":"Scherm","year":"2022","journal-title":"Mol Metab"},{"issue":"11","key":"10.1016\/j.molmet.2024.101998_bib57","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.2337\/db06-0066","article-title":"Identification of Novel HLA-A\u22170201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives","volume":"55","author":"Standifer","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2024.101998_bib58","first-page":"576219","article-title":"Detection of GAD65 autoreactive T-cells by HLA class I tetramers in type 1 diabetic patients","volume":"2009","author":"Giuliani","year":"2009","journal-title":"J Biomed Biotechnol"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib59","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/cei.13391","article-title":"Circulating beta cell-specific CD8(+) T cells restricted by high-risk HLA class I molecules show antigen experience in children with and at risk of type 1 diabetes","volume":"199","author":"Yeo","year":"2020","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib60","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1172\/JCI94549","article-title":"Autoreactive T cells in type 1 diabetes","volume":"127","author":"Pugliese","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.molmet.2024.101998_bib61","doi-asserted-by":"crossref","first-page":"44661","DOI":"10.1038\/srep44661","article-title":"CD8(+) T cells specific for the islet autoantigen IGRP are restricted in their T cell receptor chain usage","volume":"7","author":"Fuchs","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib62","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1073\/pnas.040556697","article-title":"Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes","volume":"97","author":"Fuchs","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.molmet.2024.101998_bib63","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.4049\/jimmunol.173.11.6603","article-title":"Early and quantal (by litter) expression of insulin autoantibodies in the nonobese diabetic mice predict early diabetes onset","volume":"173","author":"Melanitou","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.molmet.2024.101998_bib64","doi-asserted-by":"crossref","first-page":"645817","DOI":"10.3389\/fimmu.2021.645817","article-title":"Tolerance to proinsulin-1 reduces autoimmune diabetes in NOD mice","volume":"12","author":"Jhala","year":"2021","journal-title":"Front Immunol"},{"issue":"7039","key":"10.1016\/j.molmet.2024.101998_bib65","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature03523","article-title":"Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice","volume":"435","author":"Nakayama","year":"2005","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib66","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/eji.1830250430","article-title":"Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice","volume":"25","author":"Daniel","year":"1995","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/diab.46.1.34","article-title":"Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice","volume":"46","author":"French","year":"1997","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.molmet.2024.101998_bib68","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00125-013-3043-5","article-title":"The diagnosis of insulitis in human type 1 diabetes","volume":"56","author":"Campbell-Thompson","year":"2013","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib69","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nri3152","article-title":"Expanding roles for CD4+ T cells in immunity to viruses","volume":"12","author":"Swain","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.molmet.2024.101998_bib70","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00299027","article-title":"Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin-dependent) diabetes mellitus","volume":"30","author":"Foulis","year":"1987","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.molmet.2024.101998_bib71","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJM198508083130604","article-title":"In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis","volume":"313","author":"Bottazzo","year":"1985","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.molmet.2024.101998_bib72","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.2337\/db14-1370","article-title":"Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes","volume":"64","author":"Krogvold","year":"2015","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib73","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.4049\/jimmunol.161.8.3912","article-title":"B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice","volume":"161","author":"Serreze","year":"1998","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.molmet.2024.101998_bib74","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1084\/jem.184.5.2049","article-title":"B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new \u201cspeed congenic\u201d stock of NOD.Ig mu null mice","volume":"184","author":"Serreze","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.molmet.2024.101998_bib75","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fendo.2017.00343","article-title":"T\u00a0cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes","volume":"8","author":"Burrack","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib76","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1073\/pnas.1018973108","article-title":"Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans","volume":"108","author":"Calderon","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.molmet.2024.101998_bib77","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.4049\/jimmunol.181.10.6964","article-title":"IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes","volume":"181","author":"Calderon","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059701","article-title":"Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse","volume":"8","author":"Carrero","year":"2013","journal-title":"PLoS One"},{"issue":"37","key":"10.1016\/j.molmet.2024.101998_bib79","doi-asserted-by":"crossref","first-page":"E7776","DOI":"10.1073\/pnas.1707381114","article-title":"Imaging the emergence and natural progression of spontaneous autoimmune diabetes","volume":"114","author":"Mohan","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib80","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.2337\/db13-1658","article-title":"Hyaluronan and hyaluronan-binding proteins accumulate in both human type 1 diabetic islets and lymphoid tissues and associate with inflammatory cells in insulitis","volume":"63","author":"Bogdani","year":"2014","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib81","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1369\/0022155415576542","article-title":"Hyaluronan: a mediator of islet dysfunction and destruction in diabetes?","volume":"63","author":"Hull","year":"2015","journal-title":"J Histochem Cytochem"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib82","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1074\/jbc.RA117.000148","article-title":"Hyaluronan content governs tissue stiffness in pancreatic islet inflammation","volume":"293","author":"Nagy","year":"2018","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib83","doi-asserted-by":"crossref","first-page":"17142","DOI":"10.1038\/s41598-021-96327-2","article-title":"Enhanced CD4(+) and CD8(+) T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progresses","volume":"11","author":"Dwyer","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib84","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/db14-0443","article-title":"CXCR1\/2 inhibition blocks and reverses type 1 diabetes in mice","volume":"64","author":"Citro","year":"2015","journal-title":"Diabetes"},{"issue":"14","key":"10.1016\/j.molmet.2024.101998_bib85","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1073\/pnas.0932778100","article-title":"Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes","volume":"100","author":"Lieberman","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib86","doi-asserted-by":"crossref","first-page":"e1122","DOI":"10.1002\/cti2.1122","article-title":"Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets","volume":"9","author":"Lu","year":"2020","journal-title":"Clin Transl Immunology"},{"issue":"10","key":"10.1016\/j.molmet.2024.101998_bib87","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00125-015-3669-6","article-title":"Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms","volume":"58","author":"Brozzi","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2024.101998_bib88","article-title":"The role of beta cell stress and neo-epitopes in the immunopathology of type 1 diabetes","volume":"11","author":"Piganelli","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tim.2004.12.005","article-title":"Enterovirus protein 2B po(u)res out the calcium: a viral strategy to survive?","volume":"13","author":"van Kuppeveld","year":"2005","journal-title":"Trends Microbiol"},{"issue":"9","key":"10.1016\/j.molmet.2024.101998_bib90","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/0006-2952(76)90502-5","article-title":"Alloxan-induced diabetes-evidence for hydroxyl radical as a cytotoxic intermediate","volume":"25","author":"Heikkila","year":"1976","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.molmet.2024.101998_bib91","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.lfs.2018.11.041","article-title":"Emerging role of Unfolded Protein Response (UPR) mediated proteotoxic apoptosis in diabetes","volume":"216","author":"Pandey","year":"2019","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib92","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cell.2009.01.042","article-title":"Regulation of translation initiation in eukaryotes: mechanisms and biological targets","volume":"136","author":"Sonenberg","year":"2009","journal-title":"Cell"},{"issue":"19","key":"10.1016\/j.molmet.2024.101998_bib93","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1128\/MCB.22.19.6681-6688.2002","article-title":"The GCN2 eIF2alpha kinase is required for adaptation to amino acid deprivation in mice","volume":"22","author":"Zhang","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.molmet.2024.101998_bib94","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2121-10-61","article-title":"Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation","volume":"10","author":"Feng","year":"2009","journal-title":"BMC Cell Biol"},{"issue":"6","key":"10.1016\/j.molmet.2024.101998_bib95","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/1566524016666160523143937","article-title":"The role of the PERK\/eIF2alpha\/ATF4\/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress","volume":"16","author":"Rozpedek","year":"2016","journal-title":"Curr Mol Med"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib96","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1172\/JCI39678","article-title":"Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells","volume":"120","author":"Fonseca","year":"2010","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib97","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/JME-15-0232","article-title":"Oxidative and endoplasmic reticulum stress in beta-cell dysfunction in diabetes","volume":"56","author":"Hasnain","year":"2016","journal-title":"J\u00a0Mol Endocrinol"},{"issue":"10","key":"10.1016\/j.molmet.2024.101998_bib98","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00125-016-4060-y","article-title":"Sensitivity profile of the human EndoC-betaH1 beta cell line to proinflammatory cytokines","volume":"59","author":"Gurgul-Convey","year":"2016","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib99","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00424-010-0862-9","article-title":"Oxidative stress and beta-cell dysfunction","volume":"460","author":"Drews","year":"2010","journal-title":"Pflugers Arch"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib100","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.188.8.1445","article-title":"Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes","volume":"188","author":"Hotta","year":"1998","journal-title":"J Exp Med"},{"issue":"13","key":"10.1016\/j.molmet.2024.101998_bib101","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1074\/jbc.RA118.006219","article-title":"Pancreatic beta-cells detoxify H(2)O(2) through the peroxiredoxin\/thioredoxin antioxidant system","volume":"294","author":"Stancill","year":"2019","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226696","article-title":"N-acetyl cysteine attenuates oxidative stress and glutathione-dependent redox imbalance caused by high glucose\/high palmitic acid treatment in pancreatic Rin-5F cells","volume":"14","author":"Alnahdi","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.molmet.2024.101998_bib103","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1172\/JCI83657","article-title":"Stress-impaired transcription factor expression and insulin secretion in transplanted human islets","volume":"126","author":"Dai","year":"2016","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib104","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2337\/diabetes.52.1.93","article-title":"Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells","volume":"52","author":"Azevedo-Martins","year":"2003","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib105","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1074\/jbc.M114.627869","article-title":"How the location of superoxide generation influences the beta-cell response to nitric oxide","volume":"290","author":"Broniowska","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molmet.2024.101998_bib106","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev-biochem-072909-095555","article-title":"Endoplasmic reticulum stress and type 2 diabetes","volume":"81","author":"Back","year":"2012","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041509","article-title":"The role of oxidative stress in pancreatic beta cell dysfunction in diabetes","volume":"22","author":"Eguchi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib108","first-page":"2744","article-title":"ROS-mediated autophagy through the AMPK signaling pathway protects INS-1 cells from human islet amyloid polypeptide-induced cytotoxicity","volume":"18","author":"Xia","year":"2018","journal-title":"Mol Med Rep"},{"issue":"5","key":"10.1016\/j.molmet.2024.101998_bib109","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1096\/fj.201701100R","article-title":"MiR-184 expression is regulated by AMPK in pancreatic islets","volume":"32","author":"Martinez-Sanchez","year":"2018","journal-title":"FASEB J"},{"issue":"33","key":"10.1016\/j.molmet.2024.101998_bib110","doi-asserted-by":"crossref","first-page":"20284","DOI":"10.1074\/jbc.M115.658625","article-title":"miR-184 regulates pancreatic beta-cell function according to glucose metabolism","volume":"290","author":"Tattikota","year":"2015","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2024.101998_bib111","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mce.2013.04.027","article-title":"Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic beta cells","volume":"375","author":"Zhang","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"10.1016\/j.molmet.2024.101998_bib112","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cmet.2016.04.003","article-title":"Chronic activation of gamma2 AMPK induces obesity and reduces beta cell function","volume":"23","author":"Yavari","year":"2016","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015726","article-title":"NADPH oxidase 2-derived reactive oxygen species mediate FFAs-induced dysfunction and apoptosis of beta-cells via JNK, p38 MAPK and p53 pathways","volume":"5","author":"Yuan","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.molmet.2024.101998_bib114","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.2337\/db12-1097","article-title":"In vivo JNK activation in pancreatic beta-cells leads to glucose intolerance caused by insulin resistance in pancreas","volume":"62","author":"Lanuza-Masdeu","year":"2013","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.molmet.2024.101998_bib115","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.coph.2009.08.007","article-title":"Stress hormones: physiological stress and regulation of metabolism","volume":"9","author":"Kyrou","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.molmet.2024.101998_bib116","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4939-2895-8_5","article-title":"Regulation of glucose homeostasis by glucocorticoids","volume":"872","author":"Kuo","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.molmet.2024.101998_bib117","first-page":"317","article-title":"Molecular mechanisms linking stress and insulin resistance","volume":"21","author":"Yaribeygi","year":"2022","journal-title":"EXCLI J"},{"key":"10.1016\/j.molmet.2024.101998_bib118","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fendo.2013.00037","article-title":"Beta cell dysfunction and insulin resistance","volume":"4","author":"Cerf","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib119","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cmet.2019.05.006","article-title":"Acceleration of beta cell aging determines diabetes and senolysis improves disease outcomes","volume":"30","author":"Aguayo-Mazzucato","year":"2019","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.molmet.2024.101998_bib120","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.cmet.2019.01.021","article-title":"Targeted elimination of senescent beta cells prevents type 1 diabetes","volume":"29","author":"Thompson","year":"2019","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.molmet.2024.101998_bib121","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2337\/db17-1006","article-title":"beta-Cell DNA damage response promotes islet inflammation in type 1 diabetes","volume":"67","author":"Horwitz","year":"2018","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib122","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1073\/pnas.0700442104","article-title":"Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients","volume":"104","author":"Dotta","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6748","key":"10.1016\/j.molmet.2024.101998_bib123","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/43454","article-title":"Rapid on\/off cycling of cytokine production by virus-specific CD8+ T cells","volume":"401","author":"Slifka","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib124","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/db16-0547","article-title":"Islet-Expressed CXCL10 promotes autoimmune destruction of islet isografts in mice with type 1 diabetes","volume":"66","author":"Bender","year":"2017","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2337\/db11-0853","article-title":"Expression and regulation of chemokines in murine and human type 1 diabetes","volume":"61","author":"Sarkar","year":"2012","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib126","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.4049\/jimmunol.162.8.4576","article-title":"Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD\/CIITA-deficient mice","volume":"162","author":"Mora","year":"1999","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib127","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2337\/diab.43.3.505","article-title":"Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant","volume":"43","author":"Serreze","year":"1994","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib128","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/jaut.1997.0128","article-title":"Development of insulitis and diabetes in B cell-deficient NOD mice","volume":"10","author":"Yang","year":"1997","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.molmet.2024.101998_bib129","doi-asserted-by":"crossref","first-page":"1377322","DOI":"10.3389\/fendo.2024.1377322","article-title":"Autoimmune CD8+ T cells in type 1 diabetes: from single-cell RNA sequencing to T-cell receptor redirection","volume":"15","author":"Yang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni771","article-title":"Target cell defense prevents the development of diabetes after viral infection","volume":"3","author":"Flodstr\u00f6m","year":"2002","journal-title":"Nat Immunol"},{"issue":"21","key":"10.1016\/j.molmet.2024.101998_bib131","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1073\/pnas.0402065101","article-title":"Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity","volume":"101","author":"Poirot","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib132","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2249.2007.03580.x","article-title":"Natural killer cells are required for accelerated type 1 diabetes driven by interferon-beta","volume":"151","author":"Alba","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib133","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ni.1834","article-title":"The activating receptor NKp46 is essential for the development of type 1 diabetes","volume":"11","author":"Gur","year":"2010","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib134","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.immuni.2009.08.023","article-title":"How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets","volume":"31","author":"Feuerer","year":"2009","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib135","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2337\/diabetes.51.3.638","article-title":"Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice","volume":"51","author":"Rabinovitch","year":"2002","journal-title":"Diabetes"},{"issue":"23","key":"10.1016\/j.molmet.2024.101998_bib136","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99860","article-title":"CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus","volume":"3","author":"Vonberg","year":"2018","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib137","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.184.3.1093","article-title":"Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice","volume":"184","author":"Mueller","year":"1996","journal-title":"J\u00a0Exp Med"},{"issue":"21","key":"10.1016\/j.molmet.2024.101998_bib138","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/sj.gt.3301309","article-title":"Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer","volume":"7","author":"Cameron","year":"2000","journal-title":"Gene Ther"},{"issue":"7","key":"10.1016\/j.molmet.2024.101998_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011848","article-title":"Dendritic cells transduced to express interleukin 4 reduce diabetes onset in both normoglycemic and prediabetic nonobese diabetic mice","volume":"5","author":"Ruffner","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib140","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/mt.2008.116","article-title":"AAV8-mediated gene transfer of interleukin-4 to endogenous beta-cells prevents the onset of diabetes in NOD mice","volume":"16","author":"Rehman","year":"2008","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib141","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.2337\/db13-1236","article-title":"Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice","volume":"63","author":"Robert","year":"2014","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.molmet.2024.101998_bib142","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.158.9.4507","article-title":"A noncytolytic IL-10\/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice","volume":"158","author":"Zheng","year":"1997","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib143","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ni.3790","article-title":"A guiding map for inflammation","volume":"18","author":"Netea","year":"2017","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib144","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1210\/en.2009-0543","article-title":"Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I","volume":"150","author":"B\u00f6ni-Schnetzler","year":"2009","journal-title":"Endocrinology"},{"issue":"356","key":"10.1016\/j.molmet.2024.101998_bib145","doi-asserted-by":"crossref","first-page":"356ra119","DOI":"10.1126\/scitranslmed.aad9943","article-title":"Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression","volume":"8","author":"Hundhausen","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.molmet.2024.101998_bib146","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2017.02.002","article-title":"Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress","volume":"80","author":"Lombardi","year":"2017","journal-title":"J\u00a0Autoimmun"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib147","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00125-016-4201-3","article-title":"Interferon-alpha mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes","volume":"60","author":"Marroqui","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmet.2024.101998_bib148","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib149","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1038\/s41598-018-26471-9","article-title":"Interferon-gamma drives programmed death-ligand 1 expression on islet beta cells to limit T cell function during autoimmune diabetes","volume":"8","author":"Osum","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.molmet.2024.101998_bib150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fcimb.2019.00207","article-title":"The PD-1\/PD-L1 axis and virus infections: a delicate balance","volume":"9","author":"Schonrich","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"10.1016\/j.molmet.2024.101998_bib151","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2337\/diab.34.11.1205","article-title":"Interferon-gamma enhances the expression of the major histocompatibility class I antigens on mouse pancreatic beta cells","volume":"34","author":"Campbell","year":"1985","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.molmet.2024.101998_bib152","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0092-8674(88)90414-X","article-title":"Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma","volume":"52","author":"Sarvetnick","year":"1988","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib153","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ni.3854","article-title":"Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes","volume":"18","author":"Rouxel","year":"2017","journal-title":"Nat Immunol"},{"issue":"6865","key":"10.1016\/j.molmet.2024.101998_bib154","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/414792a","article-title":"beta-Cell death during progression to diabetes","volume":"414","author":"Mathis","year":"2001","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.molmet.2024.101998_bib155","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2337\/dbi17-0030","article-title":"Immune recognition of beta-cells: neoepitopes as key players in the loss of tolerance","volume":"67","author":"James","year":"2018","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.molmet.2024.101998_bib156","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.2337\/db13-1952","article-title":"Recognition of posttranslationally modified GAD65 epitopes in subjects with type 1 diabetes","volume":"63","author":"McGinty","year":"2014","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib157","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2337\/db14-0621","article-title":"Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes","volume":"64","author":"Rondas","year":"2015","journal-title":"Diabetes"},{"issue":"6274","key":"10.1016\/j.molmet.2024.101998_bib158","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.aad2791","article-title":"Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion","volume":"351","author":"Delong","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib159","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.cmet.2020.03.002","article-title":"Beta cell dedifferentiation induced by IRE1alpha deletion prevents type 1 diabetes","volume":"31","author":"Lee","year":"2020","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1359-6101(02)00088-6","article-title":"Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases","volume":"14","author":"Stewart","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib161","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/eji.201142374","article-title":"IFN-gamma receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells","volume":"42","author":"Yi","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.molmet.2024.101998_bib162","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-immunol-031210-101345","article-title":"Plasmacytoid dendritic cells: recent progress and open questions","volume":"29","author":"Reizis","year":"2011","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib163","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1084\/jem.20011353","article-title":"Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice","volume":"196","author":"Gagnerault","year":"2002","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib164","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.2337\/diabetes.53.12.3115","article-title":"Absence of lymph nodes in NOD mice treated with lymphotoxin-beta receptor immunoglobulin protects from diabetes","volume":"53","author":"Levisetti","year":"2004","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib165","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MED.0000000000000399","article-title":"Potential role of type I interferon in the pathogenic process leading to type 1 diabetes","volume":"25","author":"Qaisar","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib166","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nm970","article-title":"A transgenic mouse model for monitoring endoplasmic reticulum stress","volume":"10","author":"Iwawaki","year":"2004","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib167","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00262007","article-title":"Diabetes in identical twins. A study of 200 pairs","volume":"20","author":"Barnett","year":"1981","journal-title":"Diabetologia"},{"issue":"Suppl 2","key":"10.1016\/j.molmet.2024.101998_bib168","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.2337\/diabetes.54.suppl_2.S125","article-title":"Environmental triggers and determinants of type 1 diabetes","volume":"54","author":"Knip","year":"2005","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.molmet.2024.101998_bib169","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.2337\/diab.44.10.1176","article-title":"Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes","volume":"44","author":"Verge","year":"1995","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.molmet.2024.101998_bib170","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrm2199","article-title":"Signal integration in the endoplasmic reticulum unfolded protein response","volume":"8","author":"Ron","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.molmet.2024.101998_bib171","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.3390\/v7062749","article-title":"The emerging roles of viroporins in ER stress response and autophagy induction during virus infection","volume":"7","author":"Fung","year":"2015","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib172","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41591-019-0667-0","article-title":"Prospective virome analyses in young children at increased genetic risk for type 1 diabetes","volume":"25","author":"Vehik","year":"2019","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib173","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41574-022-00688-1","article-title":"Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus","volume":"18","author":"Nekoua","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib174","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/endrev\/bnad007","article-title":"Coxsackievirus and type 1 diabetes: diabetogenic mechanisms and implications for prevention","volume":"44","author":"Carr\u00e9","year":"2023","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00281-002-0100-4","article-title":"Immunopathology during coxsackievirus infection","volume":"24","author":"Whitton","year":"2002","journal-title":"Springer Semin Immunopathol"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib176","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.clim.2003.09.014","article-title":"Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells","volume":"110","author":"Horwitz","year":"2004","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib177","doi-asserted-by":"crossref","first-page":"a007724","DOI":"10.1101\/cshperspect.a007724","article-title":"Connecting type 1 and type 2 diabetes through innate immunity","volume":"2","author":"Odegaard","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.molmet.2024.101998_bib178","doi-asserted-by":"crossref","first-page":"756548","DOI":"10.3389\/fimmu.2021.756548","article-title":"Partners in crime: beta-cells and autoimmune responses complicit in type 1 diabetes pathogenesis","volume":"12","author":"Toren","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.molmet.2024.101998_bib179","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2337\/dc20-1092","article-title":"Increased incidence of pediatric type 1 diabetes with novel association with coxsackievirus A species in young children but declined incidence in adolescents in Taiwan","volume":"44","author":"Shih","year":"2021","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13098-024-01267-2","article-title":"Covid 19 and diabetes in children: advances and strategies","volume":"16","author":"Wu","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.molmet.2024.101998_bib181","doi-asserted-by":"crossref","first-page":"650158","DOI":"10.3389\/fendo.2021.650158","article-title":"Pathological beta-cell endoplasmic reticulum stress in type 2 diabetes: current evidence","volume":"12","author":"Shrestha","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib182","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1007\/s00125-013-3044-4","article-title":"Pathological endoplasmic reticulum stress mediated by the IRE1 pathway contributes to pre-insulitic beta cell apoptosis in a virus-induced rat model of type 1 diabetes","volume":"56","author":"Yang","year":"2013","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.molmet.2024.101998_bib183","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s00125-012-2604-3","article-title":"Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes","volume":"55","author":"Marhfour","year":"2012","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib184","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000496034","article-title":"Coxsackievirus B tailors the unfolded protein response to favour viral amplification in pancreatic beta cells","volume":"11","author":"Colli","year":"2019","journal-title":"J Innate Immun"},{"issue":"20","key":"10.1016\/j.molmet.2024.101998_bib185","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1128\/JVI.01151-07","article-title":"West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis","volume":"81","author":"Medigeshi","year":"2007","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.molmet.2024.101998_bib186","doi-asserted-by":"crossref","first-page":"8446","DOI":"10.1128\/JVI.01416-09","article-title":"Coxsackievirus B3 infection activates the unfolded protein response and induces apoptosis through downregulation of p58IPK and activation of CHOP and SREBP1","volume":"84","author":"Zhang","year":"2010","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.molmet.2024.101998_bib187","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nri2623","article-title":"Cytokine determinants of viral tropism","volume":"9","author":"McFadden","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.molmet.2024.101998_bib188","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9071519","article-title":"Viruses and type 1 diabetes: from enteroviruses to the virome","volume":"9","author":"Isaacs","year":"2021","journal-title":"Microorganisms"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib189","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/apm.12011","article-title":"Viral infections and molecular mimicry in type 1 diabetes","volume":"120","author":"Coppieters","year":"2012","journal-title":"APMIS"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF03401920","article-title":"T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents","volume":"4","author":"Honeyman","year":"1998","journal-title":"Mol Med"},{"issue":"11","key":"10.1016\/j.molmet.2024.101998_bib191","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrcardio.2015.108","article-title":"Viral myocarditis--diagnosis, treatment options, and current controversies","volume":"12","author":"Pollack","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.molmet.2024.101998_bib192","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","article-title":"Regulation mechanisms and signaling pathways of autophagy","volume":"43","author":"He","year":"2009","journal-title":"Annu Rev Genet"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-020-01370-4","article-title":"The beta-cell genomic landscape in T1D: implications for disease pathogenesis","volume":"21","author":"Ramos-Rodriguez","year":"2021","journal-title":"Curr Diab Rep"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib194","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cmet.2008.08.013","article-title":"Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia","volume":"8","author":"Jung","year":"2008","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.molmet.2024.101998_bib195","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2337\/dbi20-0014","article-title":"A selective look at autophagy in pancreatic beta-cells","volume":"70","author":"Pearson","year":"2021","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib196","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.4161\/auto.21994","article-title":"Autophagy plays a protective role in endoplasmic reticulum stress-mediated pancreatic beta cell death","volume":"8","author":"Bartolome","year":"2012","journal-title":"Autophagy"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib197","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1210\/en.2013-1578","article-title":"Exendin-4 improves beta-cell function in autophagy-deficient beta-cells","volume":"154","author":"Abe","year":"2013","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.molmet.2024.101998_bib198","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00125-009-1347-2","article-title":"Autophagy in human type 2 diabetes pancreatic beta cells","volume":"52","author":"Masini","year":"2009","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib199","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1507\/endocrj.EJ17-0333","article-title":"Normal pancreatic beta-cell function in mice with RIP-Cre-mediated inactivation of p62\/SQSTM1","volume":"65","author":"Honda","year":"2018","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib200","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00151.2021","article-title":"beta-Cell autophagy in the pathogenesis of type 1 diabetes","volume":"321","author":"Muralidharan","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.molmet.2024.101998_bib201","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1210\/en.2017-03273","article-title":"beta-Cell autophagy in diabetes pathogenesis","volume":"159","author":"Marasco","year":"2018","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.molmet.2024.101998_bib202","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1007\/s00125-020-05219-z","article-title":"Human enteroviral infection impairs autophagy in clonal INS(832\/13) cells and human pancreatic islet cells","volume":"63","author":"Wernersson","year":"2020","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib203","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41419-017-0121-5","article-title":"Dysfunctional autophagy following exposure to pro-inflammatory cytokines contributes to pancreatic beta-cell apoptosis","volume":"9","author":"Lambelet","year":"2018","journal-title":"Cell Death Dis"},{"issue":"12","key":"10.1016\/j.molmet.2024.101998_bib204","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/s41366-023-01369-3","article-title":"Emerging therapeutic options in the management of diabetes: recent trends, challenges and future directions","volume":"47","author":"Ansari","year":"2023","journal-title":"Int J Obes (Lond)"},{"issue":"7","key":"10.1016\/j.molmet.2024.101998_bib205","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.molmet.2024.101998_bib206","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1007\/s00125-021-05565-6","article-title":"Interactions between islets and regulatory immune cells in health and type 1 diabetes","volume":"64","author":"Budd","year":"2021","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib207","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1158\/1078-0432.CCR-18-0762","article-title":"Anti-CTLA-4 immunotherapy does not deplete FOXP3(+) regulatory T cells (Tregs) in human cancers","volume":"25","author":"Sharma","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.molmet.2024.101998_bib208","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","article-title":"Type 1 diabetes mellitus as a disease of the beta-cell (do not blame the immune system?)","volume":"17","author":"Roep","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib209","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41467-017-02763-y","article-title":"T cells specific for post-translational modifications escape intrathymic tolerance induction","volume":"9","author":"Raposo","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2337\/db12-1214","article-title":"Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes","volume":"63","author":"van Lummel","year":"2014","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib211","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00125-020-05317-y","article-title":"A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes","volume":"64","author":"Keymeulen","year":"2021","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib212","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI81722","article-title":"Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients","volume":"125","author":"Rigby","year":"2015","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.molmet.2024.101998_bib213","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.2337\/db14-0047","article-title":"Reduction in CD4 central memory T-cell subset in costimulation modulator abatacept-treated patients with recent-onset type 1 diabetes is associated with slower C-peptide decline","volume":"63","author":"Orban","year":"2014","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.molmet.2024.101998_bib214","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2337\/db11-0955","article-title":"Preventing beta-cell loss and diabetes with calcium channel blockers","volume":"61","author":"Xu","year":"2012","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.molmet.2024.101998_bib215","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","article-title":"Verapamil and beta cell function in adults with recent-onset type 1 diabetes","volume":"24","author":"Ovalle","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.molmet.2024.101998_bib216","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1210\/clinem\/dgaa791","article-title":"Rapamycin plus vildagliptin to recover beta-cell function in long-standing type 1 diabetes: a double-blind, randomized trial","volume":"106","author":"Bolla","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.molmet.2024.101998_bib217","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/gutjnl-2020-322630","article-title":"Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial","volume":"70","author":"de Groot","year":"2021","journal-title":"Gut"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824001297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824001297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T18:59:12Z","timestamp":1728500352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877824001297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":217,"alternative-id":["S2212877824001297"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2024.101998","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding the immune dance: Unraveling the interplay between beta cells and type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2024.101998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101998"}}